AIMM Therapeutics Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Employees
-
9
- Latest Deal Type
-
Out of Business
AIMM Therapeutics General Information
Description
Developer of therapeutic human monoclonal antibodies designed to offer treatment of cancer and infectious diseases. The company's human monoclonal antibodies and antibody discovery platform couples proprietary knowledge of B cell immortalization with the isolation of promising antibodies from humans or animals, enabling healthcare organizations to provide patients with quality care in a cost-efficient manner.
Contact Information
Website
www.aimmtherapeutics.comCorporate Office
- Meibergdreef 59
- 1105 BA Amsterdam
- Netherlands
Corporate Office
- Meibergdreef 59
- 1105 BA Amsterdam
- Netherlands
AIMM Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 01-Feb-2022 | Completed | Out of Business | |||
| 4. Later Stage VC | 01-Jan-2018 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 07-Jun-2013 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Jun-2009 | $1.37M | $1.37M | Completed | Startup | |
| 1. Joint Venture | 01-Jan-2004 | Completed | Startup |
AIMM Therapeutics Patents
AIMM Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2017119811-A1 | Therapeutic anti-cd9 antibody | Inactive | 08-Jan-2016 | ||
| EP-3313870-A1 | Aml antigens and uses thereof | Active | 24-Jun-2015 | ||
| EP-3313870-B1 | Aml antigens and uses thereof | Active | 24-Jun-2015 | ||
| WO-2016209079-A1 | Aml antigens and uses thereof | Inactive | 24-Jun-2015 | ||
| EP-3189077-A2 | Hepatitis c virus specific antibody | Inactive | 05-Sep-2014 | C07K16/118 |
AIMM Therapeutics Signals
AIMM Therapeutics FAQs
-
When was AIMM Therapeutics founded?
AIMM Therapeutics was founded in 2004.
-
Where is AIMM Therapeutics headquartered?
AIMM Therapeutics is headquartered in Amsterdam, Netherlands.
-
What is the size of AIMM Therapeutics?
AIMM Therapeutics has 9 total employees.
-
What industry is AIMM Therapeutics in?
AIMM Therapeutics’s primary industry is Drug Discovery.
-
Is AIMM Therapeutics a private or public company?
AIMM Therapeutics is a Private company.
-
What is AIMM Therapeutics’s current revenue?
The current revenue for AIMM Therapeutics is .
-
How much funding has AIMM Therapeutics raised over time?
AIMM Therapeutics has raised $29.7M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process